CD19 and congenital rubella syndrome: In the SCID-beige mouse model of CRS, the combination of CD19 CAR-T cells and melatonin resulted in prolonged survival, reduced systemic toxicity, and lower levels of pro-inflammatory cytokines such as IL-6 and IL-1β.